Why is Venus Remedies falling/rising?

As of 10-Jul, Venus Remedies Ltd is experiencing a decline in its stock price, currently at Rs. 463.00, which reflects a decrease of Rs. 5.8 or 1.24%. Despite hitting a new 52-week high of Rs. 487 earlier in the day, the stock has underperformed its sector by 0.67% and has fallen after two consecutive days of gains. Over the past week, the stock has shown a positive return of 1.76%, and it has significantly outperformed the benchmark Sensex, which has remained flat at -0.06%. The company has demonstrated strong financial performance, including a remarkable net profit growth of 99.81% and positive results over the last two quarters, contributing to its attractive valuation and a favorable Price to Book Value ratio of 1.1. However, the lack of domestic mutual fund investment may indicate some caution among institutional investors regarding the stock's current price.
In the broader market context, while Venus Remedies has shown strong returns of 46.91% year-to-date and 21.95% over the past year, the Sensex has only increased by 6.46% and 4.09% respectively during the same periods. This indicates that the stock has been performing well relative to the market. However, the recent price decline could be attributed to profit-taking after reaching a new high, as well as the stock's underperformance relative to its sector on the day of the decline. The rising investor participation, indicated by a 53.65% increase in delivery volume, suggests ongoing interest in the stock, but the current price movement reflects a temporary setback amidst its overall strong performance trajectory.